Classes
DEA Class; Rx
Common Brand Names; Kerydin
- Antifungal Topicals
Description
Oxaborole antifungal for onchomycosis of toenails
Effective against Trichophyton rubrum or Trichophyton mentagrophytes
Available as topical solution
Indications
Indicated for onychomycosis of the toenail(s) due to Trichophyton rubrum or Trichophyton mentagrophytes
Clean and dry nails prior to use; apply to completely cover nail surface and under tip of each nail being treated; allow solution to dry following application
Contraindications
None reported by manufacturer
Adverse Effects
Application site exfoliation (2.7%)
Ingrown toenail (2.5%)
Application site erythema (1.6%)
Application site dermatitis (1.3%)
Hypersensitivity, contact allergy
Warnings
Not for oral, ophthalmic, or intravaginal use
Avoid contact with eyes, mouth, vagina, or skin immediately surrounding treated nail; wipe away excess solution from surrounding skin
Product is flammable; avoid use near heat or open flame
Pregnancy and Lactation
There are no available data on use in pregnant women to inform a drug associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes
There is no information available on presence in human milk, effects on breastfed infant or on milk production in women who are breastfeeding
Maximum Dosage
Specific maximum dosage information not available.
Specific maximum dosage information not available.
Specific maximum dosage information not available.
6 to 12 years: Specific maximum dosage information not available.
1 to 5 years: Safety and efficacy have not been established.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Tavaborole
solution
- 43.5mg/mL (0.5%)
